ICD-10 Coding for Febrile Neutropenia(D61.818U, D70.1, D70.1A)
Learn about ICD-10 coding for febrile neutropenia, including documentation requirements and common pitfalls.
Complete code families applicable to Febrile Neutropenia
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D70.9 | Neutropenia, unspecified | Use when neutropenia is present without a specified cause. |
|
| D70.1 | Agranulocytosis secondary to chemotherapy | Use when neutropenia is directly linked to chemotherapy. |
|
| R50.81 | Fever presenting with conditions classified elsewhere | Use when fever is present with neutropenia. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutFebrile Neutropenia
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Febrile Neutropenia.
Not documenting the cause of neutropenia
Impact
Clinical: May lead to inappropriate treatment decisions., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims.
Mitigation
Ensure cause of neutropenia is documented.
Using D70.9 when the cause of neutropenia is known
Impact
Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate data on treatment outcomes.
Mitigation
Use D70.1 if neutropenia is due to chemotherapy.
Missing the link between fever and neutropenia
Impact
Reimbursement: May affect DRG assignment and reimbursement., Compliance: Failure to comply with coding standards., Data Quality: Incomplete clinical data representation.
Mitigation
Use R50.81 to indicate fever with neutropenia.
Incorrect coding of neutropenia
Impact
Risk of coding neutropenia without specifying cause.
Mitigation
Ensure detailed documentation of chemotherapy and ANC.